Stefan Schunk

Title: Innovations by Inventor Stefan Schunk

Introduction

Stefan Schunk is a notable inventor based in SØborg, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific integrin activities. His work is essential in addressing inflammatory conditions and autoimmune diseases.

Latest Patents

Stefan Schunk holds a patent for "Compounds having α4β7 integrin inhibition activity." This patent describes compounds of formula (1) and their pharmaceutically acceptable salts and solvates. The compounds function as α4β7 antagonists and are particularly useful in the prevention or treatment of inflammatory bowel disease and other inflammatory conditions.

Career Highlights

Stefan Schunk is associated with Zealand Pharma A/S, a company known for its innovative approaches in the pharmaceutical industry. His role at Zealand Pharma has allowed him to focus on developing therapies that can significantly improve patient outcomes in various inflammatory diseases.

Collaborations

[This section has been skipped due to space constraints.]

Conclusion

Stefan Schunk's contributions to pharmaceutical innovations, particularly through his patent on α4β7 integrin inhibitors, highlight his commitment to advancing medical science. His work continues to pave the way for new treatments in the field of inflammatory diseases.